Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc.

AQSZF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$39.79K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Aequus Pharmaceuticals Inc.Aequus Pharmaceuticals Inc.3.1-10%--0.6

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$39,790.00
Enterprise Value$4.36 Million
Earnings per Share$-0.02
Beta-0.21
Outstanding Shares132,634,431

Return

Return on Equity9.52%ROE
Return on Assets-334.60%
Return on Invested Capital7.34%

Valuation & Multiples

P/E Ratio3.13P/E Ratio
PEG-1.95PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue4.75
Enterprise Value to EBIT-8.61
Enterprise Value to Net Income-7
Total Debt to Enterprise0.99
Debt to Equity-0.63Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 13, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Aequus Pharmaceuticals Inc.

12 employees
CEO: Douglas Glen Janzen

Aequus Pharmaceuticals Inc. is a specialized pharmaceutical firm based in Vancouver, Canada, dedicated to the development and commercialization of medicinal products across the country. The company concentrates its efforts on several key...